CHEMED CORP
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
CHE$538.06+1.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| CONSOLIDATED BALANCE SHEETS | ||
|---|---|---|
| Chemed Corporation and Subsidiary Companies | ||
| (in thousands, except shares and per share data) | ||
| December 31, | 2023 | 2022 |
| Assets | ||
| Current assets | ||
| Cash and cash equivalents (Note 9) | $263,958 | $74,126 |
| Accounts receivable | 181,511 | 139,408 |
| Inventories | 12,004 | 10,272 |
| Prepaid income taxes | 13,166 | 18,515 |
| Prepaid expenses | 30,204 | 30,291 |
| Total current assets | 500,843 | 272,612 |
| Investments of deferred compensation plans held in trust (Notes 15 and 17) | 106,126 | 93,196 |
| Properties and equipment, at cost, less accumulated depreciation (Note 13) | 203,840 | 199,714 |
| Lease right of use asset (Note 14) | 126,387 | 135,662 |
| Identifiable intangible assets less accumulated amortization (Note 6) | 90,264 | 99,726 |
| Goodwill | 585,017 | 581,295 |
| Other assets (Note 12) | 55,618 | 59,807 |
| Total Assets | $1,668,095 | $1,442,012 |
| Liabilities | ||
| Current liabilities | ||
| Accounts payable | $64,034 | $41,884 |
| Current portion of long-term debt (Note 3) | - | 5,000 |
| Income taxes (Note 11) | 6,858 | - |
| Accrued insurance | 58,568 | 58,515 |
| Accrued compensation | 88,381 | 87,350 |
| Accrued legal | 6,386 | 4,456 |
| Short-term lease liability (Note 14) | 38,635 | 38,996 |
| Other current liabilities (Note 21) | 49,188 | 61,004 |
| Total current liabilities | 312,050 | 297,205 |
| Deferred income taxes (Note 11) | 30,321 | 38,613 |
| Long-term debt (Note 3) | - | 92,500 |
| Deferred compensation liabilities (Note 15) | 104,069 | 92,330 |
| Long-term lease liability (Note 14) | 100,776 | 110,513 |
| Other liabilities | 13,003 | 12,136 |
| Total Liabilities | 560,219 | 643,297 |
| Commitments and contingencies (Note 18) | ||
| Stockholders' Equity | ||
| Capital stock - authorized 80,000,000 shares $1 par; issued 37,183,681 shares | ||
| (2022 - 36,795,792 shares) | 37,184 | 36,796 |
| Paid-in capital | 1,341,273 | 1,149,899 |
| Retained earnings | 2,446,925 | 2,197,918 |
| Treasury stock - 22,148,927 shares (2022 - 21,920,993 shares), at cost | (2,719,588) | (2,588,145) |
| Deferred compensation payable in Company stock (Note 15) | 2,082 | 2,247 |
| Total Stockholders' Equity | 1,107,876 | 798,715 |
| Total Liabilities and Stockholders' Equity | $1,668,095 | $1,442,012 |
| The Notes to Consolidated Financial Statements are integral parts of these statements. | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.